Skip to main content
. 2022 Aug 8;34(1):33. doi: 10.1186/s43046-022-00137-0

Fig. 1.

Fig. 1

Mechanism of action of Brexpiprazole in cancer. Brexpiprazole modulates the activity of serotonin and dopamine; downregulates expression of CD133+ cells, Bmi1, Nanog, and Sox2; and reduces sphere formation ability of CSCs